Purpose: The aim of this report is dosimetric evaluation for an intraoperative fusion computed tomography (CT) as a superior predictor of 1-month CT based dosimetry in comparison to transrectal ultrasound (TRUS) in permanent interstitial prostate brachytherapy.Material and methods: Data of 65 patients treated with seed implantation were analyzed. All procedures has been performed with patients in the lithotomy position inside the O-arm system. An end-fine probe is used as a landmark to fuse TRUS and O-arm-based CT images. There was no difference in the patient's position, probe position, and timing of image acquisition between the two imaging modalities. Dose-volume histogram (DVH) parameters such as the dose to 90% of prostate volume (D 90 ) has been analyzed.Results: The area under the curve of the receiver operating characteristic tended to be larger on fusion CT than on TRUS for most DVH parameters (71.85% vs. 59.59% for D 90 ; p = 0.07). Significant relationships between fusion CT and 1-month CT were confirmed using Pearson's correlation coefficients for most DVH parameters (R = 0.48, p < 0.01 for D 90 ), although the relationship between TRUS and 1-month CT was poor. Large dose reduction (35 Gy for D 90 ) was seen from TRUS to fusion CT, especially in patients with high body weight and small prostate volume.Conclusions: Intraoperative fusion CT appears to have higher predictive power for 1-month CT-based dosimetry than TRUS. A prospective trial using fusion CT-based planning is warranted.J Contemp Brachytherapy 2016; 8, 1: 7-16 DOI: 10.5114/jcb.2016.57817Key words: brachytherapy, intraoperative CT, low dose rate, O-arm system, prostate cancer.
PurposeTransrectal ultrasound (TRUS) is the standard imaging tool for interstitial prostate brachytherapy [1]. The prostate, urethra, and rectum are usually contoured on TRUS images, and treatment is planned based on these contours. In addition, these contours could be modified in a realtime manner during surgery. Meanwhile, it is a wellknown fact that ultrasound is not suitable for imaging implanted seeds [2,3]. Although computed tomography (CT) is not available in the usual operating room, the guideline of the American Brachytherapy Society recommended CT as the gold standard for detecting seed position and calculating post-implant dose volume histograms (DVHs) [4].The O-arm ® surgical imaging system (Medtronic, Dublin, Ireland) was developed to provide real-time, intraoperative CT imaging with a large field-of-view. This system permits patients to be in the lithotomy position even during image acquisition because the bore diameter of this system (965 mm) is significantly larger than that of conventional CT (700-800 mm). However, soft tissues such as the prostate or rectum are difficult to delineate with this system because of its lower contrast resolution compared to conventional CT, although high-density structures such as bone or seeds that are made from titanium can be clearly imaged.Therefore, we combined O-arm-based CT and TRUS during surgery as a new...